In the BioHarmony Drug Report Database

"Preview" Icon

Eptifibatide

Integrilin (eptifibatide) is a protein pharmaceutical. Eptifibatide was first approved as Integrilin on 1998-05-18. It is used to treat coronary disease, myocardial infarction, and unstable angina in the USA. It has been approved in Europe to treat myocardial infarction and unstable angina.

 

Trade Name

 

Integrilin
 

Common Name

 

eptifibatide
 

ChEMBL ID

 

CHEMBL1174
 

Indication

 

coronary disease, myocardial infarction, unstable angina
 

Drug Class

 

Peptides: platelet aggregation inhibitors (glycoprotein IIb/IIIa receptor antagonists)

Image (chem structure or protein)

Eptifibatide structure rendering